What are West Pharmaceutical Services's profit margins?

West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.

Where do West Pharmaceutical Services's ratios come from?

Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

West Pharmaceutical Services WST Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	141.3%-0.9pp	142.2%-11.2pp	153.4%-8.4pp	161.8%+2.9pp
Operating margin	77.3%-4.7pp	81.9%-10.1pp	92%-13.9pp	105.9%+8.7pp
Net margin	65%-7.1pp	72.1%-4.4pp	76.5%-12.7pp	89.1%+4.1pp
EBITDA margin	99.2%-3.0pp	102.2%-7.2pp	109.4%-12.8pp	122.2%+7.6pp
Free cash flow margin	50%+3.7pp	46.3%-10.1pp	56.5%+0.9pp	55.5%+6.8pp
Returns
Return on equity	68.9%-7.1pp	76.1%-7.9pp	84%-30.1pp	114%-2.8pp
Return on assets	51.2%-5.7pp	56.8%-5.4pp	62.2%-18.7pp	80.9%+1.4pp
Return on invested capital	71.1%-11.5pp	82.6%-19.4pp	102%-34.1pp	136.1%+7.2pp
Efficiency
Asset turnover	3.2×0.0×	3.2×-0.1×	3.3×-0.4×	3.6×-0.1×
Inventory turnover	18.6×+1.0×	17.6×+0.8×	16.8×-1.4×	18.2×-1.6×
Liquidity
Current ratio	11.4×+0.7×	10.7×-3.1×	13.9×+0.3×	13.5×+1.9×
Quick ratio	8.6×+0.7×	8×-2.7×	10.7×+0.3×	10.4×+1.4×
Cash ratio	3.8×+0.3×	3.5×-2.7×	6.2×+0.4×	5.7×+1.0×
Leverage
Debt-to-equity	0.4×0.0×	0.5×0.0×	0.4×-0.1×	0.5×-0.1×
Debt-to-assets	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.4×0.0×
Net debt / EBITDA	-1.5×-0.4×	-1.1×+1.7×	-2.8×-0.8×	-2×-0.4×
Per Share
Book value per share	$162.87+12.4%	$144.93-3.0%	$149.45+14.4%	$130.65+18.2%
Valuation
Market capitalization	$70.84B-28.4%	$98.93B-8.5%	$108.13B+22.1%	$88.55B-22.1%
Enterprise value	$69.75B-28.9%	$98.14B-7.4%	$105.94B+22.0%	$86.82B-22.8%
Price / earnings	145.9×-43.4×	189.3×-5.9×	195.2×+59.3×	135.9×-68.5×
Price / sales	23.7×-10.5×	34.2×-3.1×	37.2×+6.7×	30.5×-13.0×
Price / book	23.9×-13.1×	37.1×-1.3×	38.4×+2.2×	36.2×-17.4×
EV / EBITDA	94.1×-38.4×	132.4×-1.1×	133.5×+35.6×	97.9×-51.9×
EV / sales	23.3×-10.6×	33.9×-2.6×	36.5×+6.5×	29.9×-13.1×
Free cash flow yield	8.4%+3.0pp	5.4%-0.6pp	6.1%-1.6pp	7.7%+3.1pp
Earnings yield	11%+2.6pp	8.5%+0.2pp	8.3%-3.9pp	12.1%+4.3pp
Dividend yield	1.4%+0.4pp	1%+0.1pp	0.8%-0.2pp	1%+0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about West Pharmaceutical Services.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are West Pharmaceutical Services's profit margins?: West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?: Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.